Coya Therapeutics

Advertisement

cGxPJobs Banner

Coya Therapeutics Begins Blinded Extension Phase of ALSTARS Trial for COYA 302 in ALS

HOUSTON, Texas, June 8, 2026 Coya Therapeutics, Inc. announced a significant milestone in the ongoing ALSTARS clinical trial, with...

By cGxPwire Editor
June 9, 2026

Read More

Coya’s COYA 303 Shows Promise in Neuroinflammation and Treg Boost

HOUSTON, Sept. 16, 2025 – Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company specializing in regulatory T cell...

By cGxPwire Editor
September 16, 2025

Read More

Advertisement

cGxPJobs

Directory